Drug Development

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Biologics raise unique formulation and development challenges, and industry is still on a learning curve to get the best out of these diverse and complex therapies.

Fresh Thinking in Biologic Drug Formulation

The aim of this study was to prepare taste-masked drug-resin complex using ion exchange resin Kyron T-134.

Development of Taste-Masked Oral Reconstitutable Suspension of Cetirizine Dihydrochloride

As a new decade has begun, this editorial reviews some of the biggest, brightest, and boldest happenings from the industry over the past 10 years.

Pharma’s Decade in Brief

PTE looks ahead to 2020’s edition of Pharmapack-the pharma industry’s dedicated packaging and drug delivery event.


Packing a Punch in Paris

Without careful consideration and understanding, new regulations for medical devices could lead to the withdrawal of combination products from the market.


Devices Under Scrutiny

Sanofi Pasteur will expand clinical development and manufacturing of an adjuvanted recombinant pandemic vaccine at its site in Pennsylvania.

Sanofi Expands Pandemic Flu Vaccine Manufacturing

The new Technology Excellence Center, located in Boston, MA, will further the company’s presence in the United States biopharma drug development landscape.

Stevanato Group Breaks Ground on New Technology Excellence Center

Catalent and Ethicann Pharmaceuticals have announced a partnership aimed at developing a new combination pharmaceutical-grade CBD and THC product to treat MS spasticity using Catalent’s orally disintegrating tablet technology.


Catalent, Ethicann Partner on Fast-Dissolve Cannabinoid Treatment for MS Spasticity

CPI has partnered with ImmunoBiology (ImmBio) for the development of a heat-stabilized formulation of a mutli-antigen vaccine candidate against Pneumococcal diseases.

CPI Partners with ImmunoBiology for Heat-Stabilized Formulation of Pneumococcal Vaccine

Gary Dailey is vice-president, Global Marketing, Electronic Materials, at Avantor.

Claudia BerrÃ³n is senior vice-president, Strategy and Commercial Operations, Biopharma Production at Avantor.

Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.

Formulation and Drug Delivery